Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
National Institutes of Health · Department of Health and Human Services
At a glance
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of January 25, 2027; forecast dates can change. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.397 (Cancer Centers Support Grants).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Mar 10, 2026Forecast posted
- Nov 1, 2026 (est.)Full notice expectednext date
- Jan 25, 2027 (est.)Application deadline
- Dec 1, 2027 (est.)Est. award date
- Posted
- Mar 10, 2026
- Est. close date
- Jan 25, 2027
- Est. award date
- Dec 1, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Typical awards for this program (SAM.gov listing for ALN 93.397, not this notice): Range: $57,222 to $13,733,523 Average: $2,438,722
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsU.S. Territory or Possession;
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Clinical Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas, and 3) Basic Cancer Centers, which focus on basic laboratory research. The purpose of all types of NCI-Designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this NOFO are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of Shared Resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.397
Historical data · not a predictionWho was funded under ALN 93.397
Historical data · not a predictionSince October 1, 2023, 352 grant awards had funding actions under Cancer Centers Support Grants, with 1,002 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH$90.1M
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER$76.7M
- DANA-FARBER CANCER INSTITUTE, INC.$70.3M
- THE JOHNS HOPKINS UNIVERSITY$60.4M
- FRED HUTCHINSON CANCER CENTER$58M
Agency contact (as published)
Office of Cancer Centers, National Cancer Institute (NCI)
ncicenters-r@mail.nih.gov
240-276-5600
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around November 1, 2026. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-26-149), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 2, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 20, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Sep 7, 2028
- Who can apply
- State governments, County governments, City or township governments and 12 more
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Sep 25, 2028
- Who can apply
- State governments, County governments, City or township governments and 11 more
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
National Institutes of Health- Award range
- Amount not specified
- Closes
- May 4, 2028
- Who can apply
- State governments, County governments, City or township governments and 12 more
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jul 12, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more